Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between the ages of 20 and 65 years old.
- People who have been clinically diagnosed with breast cancer at an early to mid stage (Stage I, II, or III).
- People who have already had surgery to remove part of the breast (lumpectomy) or the entire breast (mastectomy).
- People who are scheduled to begin radiation therapy treatment.
- People who have a sedentary (largely inactive) lifestyle, based on international physical activity guidelines.
- People who are able to understand and follow instructions given during the trial.
- People who are able to give written consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who currently have an infectious disease.
- People who have a heart or lung condition.
- People whose cancer has spread to other parts of the body (metastatic disease).
- People with diabetes that is not well controlled.
- People who have nerve damage or a nerve condition (neuropathy).
- People who are already physically active and meet the World Health Organization's recommended levels of physical activity.
- People who have taken part in a structured exercise program within the past 3 months.
- People who have any other condition that the research team believes may affect their safety or ability to take part in the trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34 913 24 80 64
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Systemic Immune-Inflammation Index (SII); Neutrophil-to-Lymphocyte Ratio (NLR); Platelet Count; Neutrophil Count; Lymphocyte Count; NT-proBNP; High-Sensitivity Troponin I; Body Weight; Phase angle; Fat Mass; Muscle Mass; Percentage Body Fat; Visceral fat area; Relative Lower-Limb Power: Handgrip Strength; Relative Lower-Limb Power (Chair Stand Test); Breast Cancer-Specific Functional Quality of Life; Breast Cancer-Specific Symptom Burden; Sleep Quality (PSQI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.